{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:53:49Z","timestamp":1794563629855,"version":"4.9.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,11,27]],"date-time":"2011-11-27T00:00:00Z","timestamp":1322352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00125-011-2381-4","type":"journal-article","created":{"date-parts":[[2011,11,26]],"date-time":"2011-11-26T08:43:43Z","timestamp":1322297023000},"page":"948-958","source":"Crossref","is-referenced-by-count":141,"title":["Cancer occurrence in Danish diabetic patients: duration and insulin effects"],"prefix":"10.1007","volume":"55","author":[{"given":"B.","family":"Carstensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. R.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Friis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,27]]},"reference":[{"key":"2381_CR1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00051670","volume":"2","author":"HO Adami","year":"1991","unstructured":"Adami HO, McLaughlin J, Ekbom A et al (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2:307\u2013314","journal-title":"Cancer Causes Control"},{"key":"2381_CR2","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/bjc.1994.427","volume":"70","author":"C Vecchia La","year":"1994","unstructured":"La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P (1994) A case\u2013control study of diabetes mellitus and cancer risk. Br J Cancer 70:950\u2013953","journal-title":"Br J Cancer"},{"key":"2381_CR3","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/jnci\/89.18.1360","volume":"89","author":"L Wideroff","year":"1997","unstructured":"Wideroff L, Gridley G, Mellemkj\u00e6r L et al (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89:1360\u20131365","journal-title":"J Natl Cancer Inst"},{"key":"2381_CR4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","volume":"29","author":"SL Bowker","year":"2006","unstructured":"Bowker SL, Majumdar SR, Veugelers P, Johnson JA (2006) Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 29:254\u2013258","journal-title":"Diabetes Care"},{"key":"2381_CR5","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00125-004-1415-6","volume":"47","author":"S Bonovas","year":"2004","unstructured":"Bonovas S, Filioussi K, Tsantes A (2004) Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia 47:1071\u20131078","journal-title":"Diabetologia"},{"key":"2381_CR6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10552-007-0126-y","volume":"18","author":"BA Calton","year":"2007","unstructured":"Calton BA, Chang SC, Wright ME et al (2007) History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control 18:493\u2013503","journal-title":"Cancer Causes Control"},{"issue":"7 suppl","key":"2381_CR7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","volume":"39","author":"CB Pedersen","year":"2011","unstructured":"Pedersen CB (2011) The Danish civil registration system. Scand J Public Health 39(7 suppl):22\u201325","journal-title":"Scand J Public Health"},{"key":"2381_CR8","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s00125-008-1156-z","volume":"51","author":"B Carstensen","year":"2008","unstructured":"Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K (2008) The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 51:2187\u20132196","journal-title":"Diabetologia"},{"issue":"7 suppl","key":"2381_CR9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/1403494811404278","volume":"39","author":"B Carstensen","year":"2011","unstructured":"Carstensen B, Christensen JK, Marcussen MM, Borch-Johnsen K (2011) The National Diabetes Register. Scand J Public Health 39(7 suppl):58\u201361","journal-title":"Scand J Public Health"},{"key":"2381_CR10","first-page":"535","volume":"44","author":"HH Storm","year":"1997","unstructured":"Storm HH, Michelsen EV, Clemmensen IH, Pihl J (1997) The Danish Cancer Registry\u2014history, content, quality and use. Dan Med Bull 44:535\u2013539","journal-title":"Dan Med Bull"},{"issue":"7 Suppl","key":"2381_CR11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1403494810393562","volume":"39","author":"ML Gjerstorff","year":"2011","unstructured":"Gjerstorff ML (2011) The Danish Cancer Registry. Scand J Public Health 39(7 Suppl):42\u201345","journal-title":"Scand J Public Health"},{"key":"2381_CR12","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1002\/sim.2764","volume":"26","author":"B Carstensen","year":"2007","unstructured":"Carstensen B (2007) Age\u2013period\u2013cohort models for the Lexis diagram. Stat Med 26:3018\u20133045","journal-title":"Stat Med"},{"key":"2381_CR13","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/sim.3041","volume":"27","author":"J Rosenbauer","year":"2007","unstructured":"Rosenbauer J, Strassburger K (2007) Comments on: \u201cAge\u2013period\u2013cohort models for the Lexis diagram\u201d. Stat Med 27:1557\u20131561","journal-title":"Stat Med"},{"key":"2381_CR14","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/sim.3058","volume":"27","author":"B Carstensen","year":"2007","unstructured":"Carstensen B (2007) Age\u2013period\u2013cohort models for the Lexis diagram (author\u2019s reply). Stat Med 27:1561\u20131564","journal-title":"Stat Med"},{"key":"2381_CR15","unstructured":"Carstensen B (2011) %Lexis: a SAS-macro for splitting follow-up time. http:\/\/192.38.117.59\/~bxc\/Lexis\/Lexis.sas . Accessed 19 October 2011"},{"key":"2381_CR16","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression modeling strategies","author":"FE Harrell","year":"2001","unstructured":"Harrell FE (2001) Regression modeling strategies. Springer, New York"},{"key":"2381_CR17","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter H, Fiocco M, Geskus RB (2007) Tutorial in biostatistics: competing risks and multi-state models. Stat Med 26:2389\u20132430","journal-title":"Stat Med"},{"key":"2381_CR18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1191\/0962280202sm281ra","volume":"11","author":"PK Andersen","year":"2002","unstructured":"Andersen PK, Abildstr\u00f8m SZ, Rosth\u00f8j S (2002) Competing risks as a multi-state model. Stat Methods Med Res 11:203\u2013215","journal-title":"Stat Methods Med Res"},{"issue":"5","key":"2381_CR19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2105\/AJPH.47.5.601","volume":"47","author":"J Cornfield","year":"1957","unstructured":"Cornfield J (1957) Estimation of the probability of developing a disease in the presence of competing risks. Am J Public Health Nations Health 47(5):601\u2013607","journal-title":"Am J Public Health Nations Health"},{"key":"2381_CR20","unstructured":"R Development Core Team (2010) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria"},{"key":"2381_CR21","doi-asserted-by":"crossref","first-page":"e1000201","DOI":"10.1371\/journal.pmed.1000201","volume":"6","author":"T Stocks","year":"2009","unstructured":"Stocks T, Rapp K, Bj\u00f6rge T et al (2009) Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (Me-Can): analysis of six prospective cohorts. PLoS Med 6:e1000201","journal-title":"PLoS Med."},{"key":"2381_CR22","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00125-011-2242-1","volume":"54","author":"JA Johnson","year":"2011","unstructured":"Johnson JA, Bowker SL, Richardson K, Marra CA (2011) Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias. Diabetologia 54:2263\u20132271","journal-title":"Diabetologia"},{"key":"2381_CR23","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/aje\/kwh161","volume":"159","author":"SS Coughlin","year":"2004","unstructured":"Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160\u20131167","journal-title":"Am J Epidemiol"},{"key":"2381_CR24","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00125-009-1444-2","volume":"52","author":"JM Jonasson","year":"2009","unstructured":"Jonasson JM, Ljung R, Talb\u00e4ck M, Haglund B, Gudbj\u00f6rnsdottir S, Steineck G (2009) Insulin glargine use and short-term incidence of malignancies\u2014a population-based follow-up study in Sweden. Diabetologia 52:1745\u20131754","journal-title":"Diabetologia"},{"key":"2381_CR25","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s00125-009-1453-1","volume":"52","author":"HM Colhoun","year":"2009","unstructured":"Colhoun HM, SDRN Epidemiology Group (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52:1755\u20131765, Erratum 52:2469","journal-title":"Diabetologia"},{"key":"2381_CR26","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","volume":"52","author":"CJ Currie","year":"2009","unstructured":"Currie CJ, Poole CD, Gale EA (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52:1766\u20131777","journal-title":"Diabetologia"},{"key":"2381_CR27","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00125-009-1418-4","volume":"52","author":"LG Hemkens","year":"2009","unstructured":"Hemkens LG, Grouven U, Bender R et al (2009) Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 52:1732\u20131744","journal-title":"Diabetologia"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-011-2381-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-011-2381-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-011-2381-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:49:36Z","timestamp":1558597776000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-011-2381-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,27]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["2381"],"URL":"https:\/\/doi.org\/10.1007\/s00125-011-2381-4","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,27]]}}}